Vol. 2 No. 4 (2013)

Articles

• Gastrointestinal Stromal Tumors Presenting as Surgical Emergencies: A Six-Patient Case Series

   232-236

  Fazilet Erozgen, Hüseyin Kadioglu, Mehmet Celal Kizilkaya, Muzaffer Akinci, Ahmet Kocakusak, Adnan Hut, Mehmet Gülen, Ömer Güngörür, Rafet Kaplan

  • PDF

• Short-Time Outcome of Intraoperative Radiotherapy (IORT): A Study on Side-Effects and Quality of Life in the Treatment of Early Breast Cancer

   237-245

  Caroline Page, Pierre-Alain Brioschi, Jacques Bernier

  • PDF

• Is FLT3 Internal Tandem Duplication an Unfavorable Risk Factor for High Risk Children with Acute Myeloid Leukemia? - Polish Experience

   246-253

  K. Pawinska-Wasikowska, T. Ksiazek, A. Wieczorek, M. Matysiak, B. Fic-Sikorska, E. Adamkiewicz-Drozynska, L. Maciejka-Kapuscinska, A. Chybicka, K. Potocka, J. Wachowiak, J. Skalska-Sadowska, J. Kowalczyk, B. Wojcik, M. Wysocki, S. Koltan, M. Krawczuk-Rybak, K. Muszynska-Roslan, W. Mlynarski, M. Stolarska, T. Urasinski, E. Kamienska, T. Szczepanski, R. Tomaszewska, G. Sobol-Milejska, A. Mizia-Malarz, G. Karolczyk, J. Pohorecka, M. Wieczorek, I. Karpinska-Derda, W. Balwierz

  • PDF

• Disease-Free Remission Exceeding 37 Years in Patients Treated as Children for Acute Leukemia (AL) with Immunotherapy Using Viable (Cryopreserved) Allogeneic Leukemic Cells Pages 254-26

   254-264

  Tatiana I. Bulycheva, Svetlana A. Mayakova, Simon V. Skurkovich

  • PDF

• Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma

   265-282

  Janet Wangari-Talbot, Elizabeth Hopper-Borge

  • PDF

• Weekly Neoadjuvant Ixabepilone on Surgical Feasibility and Clinical Outcomes in Locally Advanced High-Risk Prostate Cancer: A Phase II Clinical Trial

   283-288

  J.L. Layton, J.F. Renzulli II, A.M. Taber, D. Golijanin, J.E. Collins, H.H. Safran, A.E. Mega

  • PDF

• Effects of Nodal Status and Extent of Surgery on Survival in Triple Negative Breast Cancer

   289-296

  Raafat S. Alameddine, Nagi S. El Saghir, Elias Elias, Ahmad Saleh, Fady B. Geara, Sally Temraz, Ali Shamseddine

  • PDF

• Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?

   297-305

  Zeli Huang, Jiezhan Feng, Shaoen Li, Weihong Wei, Guoyi Zhang, Qiuxia Lu, Yongfeng Wu, Li Lin, Tao Xu

  • PDF

• Vemurafenib (PLX4032, Zelboraf®), a BRAF Inhibitor, Modulates ABCB1-, ABCG2-, and ABCC10-Mediated Multidrug Resistance

   306-317

  Saurabh G. Vispute, Jun-Jiang Chen, Yue-Li Sun, Kamlesh S. Sodani, Satyakam Singh, Yihang Pan, Tanaji Talele, Charles R. Ashby Jr, Zhe-Sheng Chen

  • PDF